相关实验视频
Updated: Jul 26, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
通过ARHGAP25/Wnt/ASCL2的反循环,ARHGAP25可以抑制乳腺癌的发展
Sijia Han1, Xueying Jin1, Tianyu Hu1
1Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.
ARHGAP25通过抑制扩散,迁移和入侵来抑制乳腺癌的进展. 它的下调激活了Wnt/β-catenin通路,影响瘤生长和患者的存活.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 在乳腺癌组织和细胞系中,ARHGAP25的下调.
- 目前尚不清楚ARHGAP25在乳腺癌中的具体作用和机制.
研究的目的:
- 阐明ARHGAP25在乳腺癌中的功能和分子机制.
- 研究ARHGAP25,Wnt/β-catenin通路和瘤进展之间的关系.
主要方法:
- 在乳腺癌细胞系中抑制和过度表达ARHGAP25.
- 西方涂抹和定量实时PCR分析蛋白质和基因表达.
- 在老鼠体内异种移植实验.
- 对患者数据的生物信息学分析.
主要成果:
- ARHGAP25的敲除促进了乳腺癌细胞的增殖,迁移和入侵.
- ARHGAP25沉默激活了Wnt/β-catenin通路,上调下游目标,如c-Myc,Cyclin D1和MMPs.
- 过度表达ARHGAP25抑制了瘤生长和癌症特性.
- 确定了一个负反循环,其中ASCL2抑制ARHGAP25表达.
- ARHGAP25的表达与免疫细胞透和患者的存活相关.
结论:
- 在乳腺癌中,ARHGAP25充当瘤抑制剂.
- ARHGAP25通过Rac1/PAK1-介导的Wnt/β-catenin通路调节癌症的进展.
- ARHGAP25可能成为乳腺癌治疗的潜在治疗点.
更多相关视频
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
相关概念视频
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Hedgehog Signaling Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...